ANGEL1

Across TCGA pan-cancer cohorts, ANGEL1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated ANGEL1 data layer compared with 24 for mass-spec protein and 4 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher ANGEL1 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated ANGEL1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.

HNSC, PDAC, and LSCC are the cancer types where ANGEL1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	1.000	0.538	.005	42	view →
PDAC	OS	Quartile	II,III,IV	0.234	0.712	.002	29	view →
LSCC	DFS	Median	II,III,IV	1.000	0.330	.006	5	view →
CCRCC	OS	Median	III,IV	1.000	0.684	.036	1	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

ANGEL1–HNSC (DFS)

Open the HNSC breakdown →